Literature DB >> 26440676

Prevalence and risk factors of COPD among never-smokers in two areas of Sweden - Occupational exposure to gas, dust or fumes is an important risk factor.

Stig Hagstad1, Helena Backman2, Anders Bjerg3, Linda Ekerljung4, Xiong Ye5, Linnea Hedman2, Anne Lindberg6, Kjell Torén7, Jan Lötvall4, Eva Rönmark2, Bo Lundbäck3.   

Abstract

BACKGROUND: Although active tobacco smoking is the main risk factor for COPD, COPD is not uncommon also among never-smokers. Different study locations along with different spirometric definitions of COPD have historically yielded different prevalence estimates of the disease. AIM: To study current prevalence and risk factors of COPD among never-smokers in two areas of Sweden.
METHODS: Data collected in 2008-2012 within the West Sweden Asthma Study and Obstructive Lung Disease in Northern Sweden Studies was pooled. The study population consisted of 1839 subjects who participated in spirometry and interviews. COPD was defined as post-bronchodilator a) FEV(1)/(F)VC < 0.7, b) FEV(1)/FVC < 0.7 and c) FEV(1)/FVC < lower limit of normal.
RESULTS: Of the 1839 subjects, 967 (52.6%) were never-smokers. Among the never-smoking subjects, the prevalence of COPD according to definitions a-c was 7.7%, 4.9% and 3.0%, respectively. The corresponding prevalence of GOLD grade ≥2 was 2.0%, 1.4% and 1.3%. No significant difference in prevalence between the two study areas was observed. In never-smokers, occupational exposure to gas, dust or fumes (GDF) was significantly associated with both COPD (OR 1.85, 95% CI 1.03-3.33), and GOLD ≥2 (OR 4.51, 1.72-11.9) according to definition a), after adjusting for age, educational level and exposure to passive smoking at work.
CONCLUSION: Depending on definition, prevalence of COPD among never-smokers was 3.0-7.7%, whereas GOLD ≥2 was present in 1.3-2.0%. Occupational exposure to GDF remained independently and significantly associated with COPD regardless of spirometric definition of the disease.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  COPD; Epidemiology; Never smokers; Population study; Risk factors

Mesh:

Substances:

Year:  2015        PMID: 26440676     DOI: 10.1016/j.rmed.2015.09.012

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  16 in total

1.  Pulmonary Dysfunction Augmenting Bacterial Aerosols in Leather Tanneries of Punjab, Pakistan.

Authors:  Fiza Sarwar; Khan Alam; Chung Wai Chow; Muhammad Saeed; Riffat Naseem Malik
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-10-27

2.  New evidence of increased risk of rhinitis in subjects with COPD: a longitudinal population study.

Authors:  Joel Bergqvist; Anders Andersson; Anna-Carin Olin; Nicola Murgia; Linus Schiöler; Mogens Bove; Johan Hellgren
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-10-19

Review 3.  Defining and targeting health disparities in chronic obstructive pulmonary disease.

Authors:  Roy A Pleasants; Isaretta L Riley; David M Mannino
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-10-04

4.  Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease among Nonsmokers: Fifth Korea National Health and Nutrition Examination Survey (2010-2012).

Authors:  Heeyoung Oh; Ye-Eun Lee
Journal:  Osong Public Health Res Perspect       Date:  2016-11-16

Review 5.  The epidemiology of noncommunicable respiratory disease in sub-Saharan Africa, the Middle East, and North Africa.

Authors:  Rana Ahmed; Ryan Robinson; Kevin Mortimer
Journal:  Malawi Med J       Date:  2017-06       Impact factor: 0.875

6.  High prevalence of undiagnosed COPD among patients evaluated for suspected myocardial ischaemia.

Authors:  Andreas Jönsson; Artur Fedorowski; Gunnar Engström; Per Wollmer; Viktor Hamrefors
Journal:  Open Heart       Date:  2018-10-25

Review 7.  The role of environmental exposure to non-cigarette smoke in lung disease.

Authors:  Rajendra Kc; Shakti D Shukla; Sanjay S Gautam; Philip M Hansbro; Ronan F O'Toole
Journal:  Clin Transl Med       Date:  2018-12-05

8.  Real-world evidence effect of budesonide+formoterol Spiromax on patients with asthma and chronic obstructive pulmonary disease in Sweden.

Authors:  Christer Janson; Hicham Benhaddi; Michael Törnblom; Milica Uhde; Gunnar Johansson
Journal:  Eur Clin Respir J       Date:  2019-09-13

9.  Smoking from a Younger Age Is the Dominant Factor in the Incidence of Chronic Obstructive Pulmonary Disease: Case-Control Study.

Authors:  Winda Safitri; Santi Martini; Kurnia Dwi Artanti; Chung-Yi Li
Journal:  Int J Environ Res Public Health       Date:  2021-06-04       Impact factor: 3.390

10.  Prevalence and characteristics of COPD among pneumoconiosis patients at an occupational disease prevention institute: a cross-sectional study.

Authors:  Yating Peng; Xin Li; Shan Cai; Yan Chen; Weirong Dai; Wenfeng Liu; Zijing Zhou; Jiaxi Duan; Ping Chen
Journal:  BMC Pulm Med       Date:  2018-01-29       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.